GRN No. 1007

Bacillus subtilis strain R0179

• Intended Use: Intended for use as an ingredient in baked goods and baking mixes, beverage and beverage bases, breakfast cereals, chewing gum, confections and frostings, dairy product analogs, fruit and water ices, nuts and nut products, plant protein products, processed fruits and fruit juices, and snack foods at a maximum level of 10⁹ colony forming units/serving.
• Basis: Scientific procedures
• Notifier: Lallemand Health Solutions
• Notifier Address: 17975 rue des Gouverneurs; Mirabel, Québec; J7J2K7; CANADA
• GRAS Notice (releasable information): GRN 1007 part 1 (in PDF) (15.5 MB)
• Part 2: GRN 1007 part 2 (in PDF) (13.1 MB)
• Part 3: GRN 1007 part 3 (in PDF) (13.2 MB)
• Part 4: GRN 1007 part 4 (in PDF) (12.1 MB)
• Part 5: GRN 1007 part 5 (in PDF) (18.3 MB)
• Part 6: GRN 1007 part 6 (in PDF) (11.2 MB)
• Part 7: GRN 1007 part 7 (in PDF) (6.2 MB)
• Date of closure: Dec 16, 2022
• FDA's Letter: At the notifier's request, FDA ceased to evaluate this notice (in PDF) (184 kB)